ClinicalTrials.gov
ClinicalTrials.gov Menu

A Survey of Google Glass by Orthopaedic Trauma Patients and Surgeons (GoogleGlass)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02221115
Recruitment Status : Active, not recruiting
First Posted : August 20, 2014
Last Update Posted : March 9, 2017
Sponsor:
Information provided by (Responsible Party):
Edward Harvey, McGill University Health Center

Brief Summary:

Patients seen in the Orthopaedic Trauma clinic will be asked to consent for potential video/picture recording using the Google Glass device during their visit with the orthopaedic surgeon or resident.

The investigators want to record the patient's level of acceptance and response to this new technology. There are two arms: Patients seen by a doctor wearing the Google Glass device and those that will not be exposed. Both groups will be asked to complete a survey after their clinic visit.

The device users (doctor) will complete a survey which will evaluate how effective this new tool is in the Orthopaedic clinical setting.


Condition or disease Intervention/treatment Phase
Orthopedic Disorders Trauma Device: Google Glass Not Applicable

Detailed Description:

Google Glass is a new low-profile wearable technology that allows physicians to record hands-free video and pictures and to directly video link and communicate with other wearers of this device. In addition to this, the device has a heads up display that is capable of searching the internet on voice command. The device has the same functionality as a smart phone with the benefit of being hands-free and wearable. The device is currently in a beta testing period where "Explorers" are accepted by application to a program to use and assess the device. The investigators have been able to obtain three of these devices.

The Google Glass device has the ability to help improve connectivity between physicians not in the same locale, increase efficiency and provide better access to vital information used in a medical and surgical setting. The device has clear teaching implications and will enable academic physicians to disseminate information to more students and in situations not previously possible. As the device evolves its potential to do more will likely develop further. It is important to assess the impact of this rapidly growing field on patient sentiment and wellbeing. As this is a very new device, very few studies have been done to assess its application in Medicine and specifically orthopaedic surgery. So far only very specific and small studies have been done with regard to immunochromatographic analysis, pharmacology, forensic medicine and Parkinson's disease. The investigators are aiming to assess the applications and patient perspective of this device on a much larger scale. The investigators feel this technology and its future offspring could be polarizing with regard to patient response. This could be an important element to consider in the future development of its clinical applications.

There are no direct medical risks to the patient. No decisions regarding patient care will be dependent on the device.

Study Objective Primary question: What is the patient's level of acceptance and response to this new technology? Secondary question: From a doctor's perspective, how effective is this new tool in the Orthopaedic clinical setting?

Design Patients seen in the Orthopaedic Trauma clinic will be asked to consent for potential video/picture recording using the Google Glass device during their visit with the orthopaedic surgeon or resident. Eligible patients will be assigned to one of two consulting rooms: one with the Google Glass device, one without.

Patients will therefore have a 50.50 chance of encountering the Google Glass.

Any images or videos taken will not show the patients face, all measures will be taken to ensure confidentiality. Both groups will be asked to complete a small survey on a locked password protected iPad after their visit so as to record their acceptability of this new technology in a clinical setting. Participants that experienced the device will also be required to comment on their experience. The device user (surgeon/resident) will also complete a survey so as to record their experience using the hands free camera and recording device.

The information gathered will be saved on a password protected drive and will be used for discussion and analysis between the investigators to help develop the potential future teaching and clinical applications of the device.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 127 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Survey-driven Evaluation of Patients Response to the Introduction of Google Glass in the Orthopaedic Trauma Clinic
Study Start Date : August 2014
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2018

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Google Glass
Investigators using Google Glass during clinic visit
Device: Google Glass
The device is a wearable, voice-controlled Android device that resembles a pair of eyeglasses and displays information directly in the user's field of vision
No Intervention: No Google Glass
Investigator will not be using Google Glass during clinic visit



Primary Outcome Measures :
  1. Patient Evaluation Survey [ Time Frame: Day one ]

Secondary Outcome Measures :
  1. Surgeon Evaluation Survey [ Time Frame: Day one ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All patients seen in the Montreal general Hospital (MGH) - Orthopaedic Trauma Clinic and capable of reading French or English.

Exclusion Criteria:

  • All patients that have cognitive impairment or language difficulties that would impede completion of the survey will be excluded from the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02221115


Locations
Canada, Quebec
Montreal General Hospital
Montreal, Quebec, Canada, H3G 1A4
Sponsors and Collaborators
McGill University Health Center
Investigators
Principal Investigator: Edward J Harvey, MDCM FRCSC RI-MUHC

Responsible Party: Edward Harvey, MDCM FRCSC, McGill University Health Center
ClinicalTrials.gov Identifier: NCT02221115     History of Changes
Other Study ID Numbers: SDR 14.135
RI-MUHC - MGH ( Other Identifier: RI-MUHC - Montreal General Hospital )
First Posted: August 20, 2014    Key Record Dates
Last Update Posted: March 9, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Edward Harvey, McGill University Health Center:
Google Glass device
Evaluation
patient's
response
to new technology
clinical setting

Additional relevant MeSH terms:
Wounds and Injuries
Musculoskeletal Diseases
Methamphetamine
Central Nervous System Stimulants
Physiological Effects of Drugs
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Dopamine Uptake Inhibitors